Selected research
Market Structure
Global Pharmaceutical Unit Dose Packaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pharmaceutical Unit Dose Packaging market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Pharmaceutical Unit Dose Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharmaceutical Unit Dose Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Unit Dose Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pharmaceutical Unit Dose Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pharmaceutical Unit Dose Packaging include Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bristol-Myers Squibb Company, AbbVie Inc., UDG Healthcare plc, Comar LLC, Berry Global and Gerresheimer AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Pharmaceutical Unit Dose Packaging market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharmaceutical Unit Dose Packaging and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharmaceutical Unit Dose Packaging sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceutical Unit Dose Packaging market size, projected growth trends, production technologies, key applications, and end-use industries.
Pharmaceutical Unit Dose Packaging Segment by Company
Pfizer Inc.
Johnson & Johnson
Merck & Co. Inc.
Bristol-Myers Squibb Company
AbbVie Inc.
UDG Healthcare plc
Comar LLC
Berry Global
Gerresheimer AG
Amcor plc
Pharmaceutical Unit Dose Packaging Segment by Type
Prefilled Syringes Cartridges
Vials Pharmaceutical Unit Dose Packaging
Ampoules Pharmaceutical Unit Dose Packaging
Blisters Pharmaceutical Unit Dose Packaging
Others
Pharmaceutical Unit Dose Packaging Segment by Application
Orals
Respiratory Therapy
Wound Care
Biologics
Injectable
Ophthalmic
Others
Pharmaceutical Unit Dose Packaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Unit Dose Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Unit Dose Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Unit Dose Packaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pharmaceutical Unit Dose Packaging market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Unit Dose Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmaceutical Unit Dose Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pharmaceutical Unit Dose Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Prefilled Syringes Cartridges
- Vials Pharmaceutical Unit Dose Packaging
- Ampoules Pharmaceutical Unit Dose Packaging
- Blisters Pharmaceutical Unit Dose Packaging
- Others
Applications
- Orals
- Respiratory Therapy
- Wound Care
- Biologics
- Injectable
- Ophthalmic
- Others
Companies covered
- Pfizer Inc.
- Johnson & Johnson
- Merck & Co. Inc.
- Bristol-Myers Squibb Company
- AbbVie Inc.
- UDG Healthcare plc
- Comar LLC
- Berry Global
- Gerresheimer AG
- Amcor plc
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pharmaceutical Unit Dose Packaging Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pharmaceutical Unit Dose Packaging Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Pharmaceutical Unit Dose Packaging Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Pharmaceutical Unit Dose Packaging Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Pharmaceutical Unit Dose Packaging Market Dynamics
- 2.1 Pharmaceutical Unit Dose Packaging Industry Trends
- 2.2 Pharmaceutical Unit Dose Packaging Industry Drivers
- 2.3 Pharmaceutical Unit Dose Packaging Industry Opportunities and Challenges
- 2.4 Pharmaceutical Unit Dose Packaging Industry Restraints
3 Pharmaceutical Unit Dose Packaging Market by Manufacturers
- 3.1 Global Pharmaceutical Unit Dose Packaging Revenue by Manufacturers (2021-2026)
- 3.2 Global Pharmaceutical Unit Dose Packaging Sales by Manufacturers (2021-2026)
- 3.3 Global Pharmaceutical Unit Dose Packaging Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Pharmaceutical Unit Dose Packaging Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pharmaceutical Unit Dose Packaging Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Pharmaceutical Unit Dose Packaging Manufacturers, Product Type & Application
- 3.7 Global Pharmaceutical Unit Dose Packaging Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pharmaceutical Unit Dose Packaging Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pharmaceutical Unit Dose Packaging Players Market Share by Revenue in 2025
- 3.8.3 2025 Pharmaceutical Unit Dose Packaging Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Unit Dose Packaging Market by Type
- 4.1 Pharmaceutical Unit Dose Packaging Type Introduction
- 4.1.1 Prefilled Syringes Cartridges
- 4.1.2 Vials Pharmaceutical Unit Dose Packaging
- 4.1.3 Ampoules Pharmaceutical Unit Dose Packaging
- 4.1.4 Blisters Pharmaceutical Unit Dose Packaging
- 4.1.5 Others
- 4.2 Global Pharmaceutical Unit Dose Packaging Sales by Type
- 4.2.1 Global Pharmaceutical Unit Dose Packaging Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pharmaceutical Unit Dose Packaging Sales by Type (2021-2032)
- 4.2.3 Global Pharmaceutical Unit Dose Packaging Sales Market Share by Type (2021-2032)
- 4.3 Global Pharmaceutical Unit Dose Packaging Revenue by Type
- 4.3.1 Global Pharmaceutical Unit Dose Packaging Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Pharmaceutical Unit Dose Packaging Revenue by Type (2021-2032)
- 4.3.3 Global Pharmaceutical Unit Dose Packaging Revenue Market Share by Type (2021-2032)
5 Pharmaceutical Unit Dose Packaging Market by Application
- 5.1 Pharmaceutical Unit Dose Packaging Application Introduction
- 5.1.1 Orals
- 5.1.2 Respiratory Therapy
- 5.1.3 Wound Care
- 5.1.4 Biologics
- 5.1.5 Injectable
- 5.1.6 Ophthalmic
- 5.1.7 Others
- 5.2 Global Pharmaceutical Unit Dose Packaging Sales by Application
- 5.2.1 Global Pharmaceutical Unit Dose Packaging Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pharmaceutical Unit Dose Packaging Sales by Application (2021-2032)
- 5.2.3 Global Pharmaceutical Unit Dose Packaging Sales Market Share by Application (2021-2032)
- 5.3 Global Pharmaceutical Unit Dose Packaging Revenue by Application
- 5.3.1 Global Pharmaceutical Unit Dose Packaging Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Pharmaceutical Unit Dose Packaging Revenue by Application (2021-2032)
- 5.3.3 Global Pharmaceutical Unit Dose Packaging Revenue Market Share by Application (2021-2032)
6 Global Pharmaceutical Unit Dose Packaging Sales by Region
- 6.1 Global Pharmaceutical Unit Dose Packaging Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pharmaceutical Unit Dose Packaging Sales by Region (2021-2032)
- 6.2.1 Global Pharmaceutical Unit Dose Packaging Sales by Region (2021-2026)
- 6.2.2 Global Pharmaceutical Unit Dose Packaging Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pharmaceutical Unit Dose Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Pharmaceutical Unit Dose Packaging Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Pharmaceutical Unit Dose Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Pharmaceutical Unit Dose Packaging Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Pharmaceutical Unit Dose Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Pharmaceutical Unit Dose Packaging Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Pharmaceutical Unit Dose Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Pharmaceutical Unit Dose Packaging Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Pharmaceutical Unit Dose Packaging Revenue by Region
- 7.1 Global Pharmaceutical Unit Dose Packaging Revenue by Region
- 7.1.1 Global Pharmaceutical Unit Dose Packaging Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Pharmaceutical Unit Dose Packaging Revenue by Region (2021-2026)
- 7.1.3 Global Pharmaceutical Unit Dose Packaging Revenue by Region (2027-2032)
- 7.1.4 Global Pharmaceutical Unit Dose Packaging Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Pharmaceutical Unit Dose Packaging Revenue (2021-2032)
- 7.2.2 North America Pharmaceutical Unit Dose Packaging Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Pharmaceutical Unit Dose Packaging Revenue (2021-2032)
- 7.3.2 Europe Pharmaceutical Unit Dose Packaging Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Pharmaceutical Unit Dose Packaging Revenue (2021-2032)
- 7.4.2 Asia-Pacific Pharmaceutical Unit Dose Packaging Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Pharmaceutical Unit Dose Packaging Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Pharmaceutical Unit Dose Packaging Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Pfizer Inc.
- 8.1.1 Pfizer Inc. Company Information
- 8.1.2 Pfizer Inc. Business Overview
- 8.1.3 Pfizer Inc. Pharmaceutical Unit Dose Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Pfizer Inc. Pharmaceutical Unit Dose Packaging Product Portfolio
- 8.1.5 Pfizer Inc. Recent Developments
- 8.2 Johnson & Johnson
- 8.2.1 Johnson & Johnson Company Information
- 8.2.2 Johnson & Johnson Business Overview
- 8.2.3 Johnson & Johnson Pharmaceutical Unit Dose Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Johnson & Johnson Pharmaceutical Unit Dose Packaging Product Portfolio
- 8.2.5 Johnson & Johnson Recent Developments
- 8.3 Merck & Co. Inc.
- 8.3.1 Merck & Co. Inc. Company Information
- 8.3.2 Merck & Co. Inc. Business Overview
- 8.3.3 Merck & Co. Inc. Pharmaceutical Unit Dose Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Merck & Co. Inc. Pharmaceutical Unit Dose Packaging Product Portfolio
- 8.3.5 Merck & Co. Inc. Recent Developments
- 8.4 Bristol-Myers Squibb Company
- 8.4.1 Bristol-Myers Squibb Company Company Information
- 8.4.2 Bristol-Myers Squibb Company Business Overview
- 8.4.3 Bristol-Myers Squibb Company Pharmaceutical Unit Dose Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Bristol-Myers Squibb Company Pharmaceutical Unit Dose Packaging Product Portfolio
- 8.4.5 Bristol-Myers Squibb Company Recent Developments
- 8.5 AbbVie Inc.
- 8.5.1 AbbVie Inc. Company Information
- 8.5.2 AbbVie Inc. Business Overview
- 8.5.3 AbbVie Inc. Pharmaceutical Unit Dose Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 AbbVie Inc. Pharmaceutical Unit Dose Packaging Product Portfolio
- 8.5.5 AbbVie Inc. Recent Developments
- 8.6 UDG Healthcare plc
- 8.6.1 UDG Healthcare plc Company Information
- 8.6.2 UDG Healthcare plc Business Overview
- 8.6.3 UDG Healthcare plc Pharmaceutical Unit Dose Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 UDG Healthcare plc Pharmaceutical Unit Dose Packaging Product Portfolio
- 8.6.5 UDG Healthcare plc Recent Developments
- 8.7 Comar LLC
- 8.7.1 Comar LLC Company Information
- 8.7.2 Comar LLC Business Overview
- 8.7.3 Comar LLC Pharmaceutical Unit Dose Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Comar LLC Pharmaceutical Unit Dose Packaging Product Portfolio
- 8.7.5 Comar LLC Recent Developments
- 8.8 Berry Global
- 8.8.1 Berry Global Company Information
- 8.8.2 Berry Global Business Overview
- 8.8.3 Berry Global Pharmaceutical Unit Dose Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Berry Global Pharmaceutical Unit Dose Packaging Product Portfolio
- 8.8.5 Berry Global Recent Developments
- 8.9 Gerresheimer AG
- 8.9.1 Gerresheimer AG Company Information
- 8.9.2 Gerresheimer AG Business Overview
- 8.9.3 Gerresheimer AG Pharmaceutical Unit Dose Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Gerresheimer AG Pharmaceutical Unit Dose Packaging Product Portfolio
- 8.9.5 Gerresheimer AG Recent Developments
- 8.10 Amcor plc
- 8.10.1 Amcor plc Company Information
- 8.10.2 Amcor plc Business Overview
- 8.10.3 Amcor plc Pharmaceutical Unit Dose Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Amcor plc Pharmaceutical Unit Dose Packaging Product Portfolio
- 8.10.5 Amcor plc Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Pharmaceutical Unit Dose Packaging Value Chain Analysis
- 9.1.1 Pharmaceutical Unit Dose Packaging Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Pharmaceutical Unit Dose Packaging Production Mode & Process
- 9.2 Pharmaceutical Unit Dose Packaging Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pharmaceutical Unit Dose Packaging Distributors
- 9.2.3 Pharmaceutical Unit Dose Packaging Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst